Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 3/2002

01-09-2002 | Original article

Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: a multicenter phase I/II study

Authors: Yashushi Mitachi, Yuh Sakata, Atsushi Ohtsu, Ichinosuke Hyodo, Kenichi Katsu, Motonori Sairenji, Soh Saitoh, Toshikazu Suwa, Toshinobu Sato, Yoshinori Miyata

Published in: Gastric Cancer | Issue 3/2002

Login to get access
Metadata
Title
Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: a multicenter phase I/II study
Authors
Yashushi Mitachi
Yuh Sakata
Atsushi Ohtsu
Ichinosuke Hyodo
Kenichi Katsu
Motonori Sairenji
Soh Saitoh
Toshikazu Suwa
Toshinobu Sato
Yoshinori Miyata
Publication date
01-09-2002
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 3/2002
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s101200200028

Other articles of this Issue 3/2002

Gastric Cancer 3/2002 Go to the issue

Original article

Prognostic significance of serum superoxide dismutase activity in patients with gastric cancer

Original article

Early gastric carcinoma: spread and multicentricity

Original article

Surgery for gastric cancer increases plasma levels of vascular endothelial growth factor and von Willebrand factor

Short communication

Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells

Letter to the editor

Result of an endoscopic mucosal resection demonstrated at the International Gastric Cancer Congress in New York

Original article

BGP expression in gastric biopsies may predict the development of new lesions after local treatment for early gastric cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits